Members Login

Nov
28

Drug Tariff Preface - Do You Read Yours?

BY GREG BULL  |  POSTED IN GENERAL NEWS
Item Pack Size Drug Tariff Change
Co-dydramol 20mg/500mg tablets 112 Category C Remedeine will be:
112 Category A
Co-dydramol 30mg/500mg tablets 56 Category C Remedeine Forte will be:
56 Category A
Colestyramine 4g oral powder sachets sugar free 50 Category C Questran Light will be:
50 Category A
Ethinylestradiol 35microgram / Norgestimate 250microgram tablets 63 Category C Cilest will be:
63 Category C Cilique
Sevelamer 2.4g oral powder sachets sugar free 60 Category A will be:
60 Category C Renvela

Drug tariff Preface - Do You read Yours?

Every month in the Drug Tariff online version and paper copy, in a section called The Preface, the following month’s changes to the Drug Tariff are listed.

The above table is taken from the November 2019 Drug Tariff and shows changes to the Drug Tariff to be implemented on the 1st of December 2019.

How do you use this information?

Look at the table above line by line.

Firstly you can see that for a prescription written for Co-dydramol 20mg/500mg tablets x 112 the current reimbursement price is based on the brand Remedeine.

Secondly you can see that for a prescription written for Co-dydramol 30mg/500mg tablets x 56 the current reimbursement price is based on the brand Remedeine Forte.

And that for a prescription written for Colestyramine 4g oral powder sachets sugar free x 50 the reimbursement price is based on the brand Questran Light.

This means that the reimbursement price for all of the above is [mostly] steady and stable and you can work out what you are going to be paid each month for dispensing these items.

However, these products are moving from Category C to Category A from December 1st, 2019. This means that from December 1st, any prescriptions written generically for these items will be reimbursed via the pricing mechanism for Category A medicines and NOT the specific brand used currently. So after Dec 1st, if you dispense any of the brands mentioned above, you would need to check their reimbursement price against the generic price in order to ensure you aren’t losing out.

The medicine Ethinylestradiol 35microgram / Norgestimate 250microgram tablets is having its reimbursement price changed from the brand Cilest to Cilique. This can happen if a certain brand is being discontinued or if the brand is unavailable. In some cases, where there may be confusion over which brand to dispense or for reasons of continuity of supply, that the prescriber makes a clinical decision to prescribe by brand.

And finally Sevelamer 2.4g oral powder sachets sugar free is moving from Cat A to Cat C and reimbursement will be based on the brand Renvela from Dec 1st. Check Renvela reimbursement price vs generic purchase price. If the Renvela price is greater than generic purchase price, you can prescribe generically and be reimbursed the Cat C price.

Remember the PATIENT must always come first, clinical considerations are always more important than financial decisions when it comes to prescribing.